Roxy vs SEDA 7OH: Clean Architecture or Warehouse Muscle?
Roxy and SEDA both sell range, but with different blueprints. Roxy keeps four SKUs across 20, 60, and 100 mg in counts from 5 to 30, a clean map of the light-to-heavy path. SEDA goes bigger everywhere: 50 to 250 mg per tablet, counts to 30, plus a 120 mg pseudo line. The core difference: Roxy curates; SEDA stocks.
Roxy (20–100 mg, 5–30 ct • Curated map) vs SEDA (50–250 mg + pseudo • The warehouse)
Quick verdict
Buy Roxy if you want the light tier and a simple catalog, 20 mg tablets in 10 and 30-counts that SEDA never offers, plus 60 and 100 mg rungs above. Buy SEDA if you want strength and volume at better rates, 50 mg tablets from $24.99, 100 mg Bars, a 250 mg heavyweight at $0.042/mg, and a pseudo side line.
- Roxy: Pick for the light tier and clean choices
- SEDA: Pick for heavy strength and volume value
At-a-glance comparison
| Spec | Roxy | SEDA |
|---|---|---|
| SKU count | 4 | 6 (5 7-OH plus 1 pseudo) |
| Per-tablet dose range | 20 – 100 mg | 50 – 250 mg (plus 120 mg pseudo) |
| Pack sizes | 5, 10, 30 ct | 3, 5, 6, 10, 20, 30 ct |
| Entry SKU | 200 mg / 10 ct, $44.99 | 250 mg / 5 ct, $24.99 |
| Top single-bottle SKU | 1000 mg / 10 ct, $149.99 | 2500 mg / 10 ct, $104.99 |
| Best per-mg (single bottle) | $0.15/mg (1000 mg / 10 ct) | $0.042/mg (2500 mg / 10 ct) |
| Best per-mg (bulk) | $0.15/mg (no bulk box) | $0.042/mg (no box needed) |
| Strongest single tablet | 100 mg | 250 mg |
| Typical onset | 20–35 min | 20–40 min |
| Best for | Light-tier regulars, simple shoppers | Volume buyers and heavyweights |
Deep Dive
Potency and formulation deep dive
Roxy's map reads in one glance. The 200 mg / 10 ct ($44.99) and 600 mg / 30 ct ($119.99) run 20 mg per tablet, light dosing in regular or month-scale counts around $0.20/mg. The XL 300 mg / 5 ct ($49.99) covers 60 mg, and the 1000 mg / 10 ct ($149.99) tops out at 100 mg per tablet, $0.15/mg. The premium is real, but so is the light tier, territory SEDA ignores entirely.
SEDA's warehouse starts where Roxy thins out. Fifty-milligram tablets come in a 5-count ($24.99, $0.10/mg) or a 30-count ($99.99, $0.067/mg). The 100 mg tier runs 6-count Bars ($45.99) or a 2000 mg / 20 ct ($187.99). The 2500 mg / 10 ct ($104.99) delivers 250 mg per tablet at $0.042/mg, the strongest and best-priced unit on this page, and the Pseudo 360 mg / 3 ct ($23.99, 120 mg per tablet) adds a chemistry Roxy lacks.
Range
Product range and SKU depth
Roxy lists four SKUs across three strengths and three counts.
SEDA lists roughly six SKUs across four strengths, six counts, and two chemistries. Both brands skip bulk boxes; SEDA's long counts fill that role.
Quality
Quality, transparency, and lab testing
Both brands ship through 7oh.com's standard batch QC covering alkaloid assay, heavy metals (Pb, Cd, Hg, As), and microbial contamination. SEDA's 250 mg tablets carry the heaviest per-unit assay stakes here, and its pseudo line adds a second standard. Roxy's 30-count spans a month of light tablets from one batch. Neither publishes third-party COAs prominently, and neither has had a publicly reported recall.
Top Picks From These Brands
Best-selling Roxy and SEDA products on 7oh.com, side by side.
Pros and cons
Roxy vs SEDA — pros and cons below.
- Left brand pro: 20 mg tier in 10 and 30-counts, unserved by SEDA.
- Left brand pro: Four-SKU catalog reads instantly.
- Left brand pro: 60 mg XL bridges light and heavy.
- Left brand pro: Month-scale light bottle for routine users.
- Left brand con: $0.15 to $0.22/mg, premium pricing throughout.
- Left brand con: Ceiling stops at 100 mg.
- Left brand con: No pseudo or variant line.
- Left brand con: Loses every value comparison above 50 mg.
- Right brand pro: 250 mg tablet at $0.042/mg, page-best on both counts.
- Right brand pro: Counts to 30 at the 50 mg tier.
- Right brand pro: Pseudo side line at 120 mg per tablet.
- Right brand pro: Better rates than Roxy at every shared strength.
- Right brand con: Nothing below 50 mg per tablet.
- Right brand con: $187.99 20-count is a big single outlay.
- Right brand con: Catalog takes research to navigate.
- Right brand con: Bars, standard, and pseudo naming blurs.
Who Should Choose
Who should choose Roxy?
Pick Roxy if you dose light or value a catalog you can hold in your head. The 20 mg 30-count is a genuinely rare product, and the path upward is clearly marked. Roxy is the right brand for light-tier regulars who pay a little for clarity.
Who Should Choose
Who should choose SEDA?
Pick SEDA if your dose starts at 50 mg and your orders run deep. Every tier is cheaper than Roxy's equivalent, the 250 mg flagship stands alone, and the pseudo line is a bonus lane. SEDA is the right brand for volume-minded heavier users.
Final Verdict
Final verdict
Roxy wins the light tier and the simplicity contest. SEDA wins strength, volume, rates, and chemistry options. Light dosers go Roxy. Everyone at 50 mg and above goes SEDA. Both carry 7oh.com's standard QC baseline.
Shop The Comparison
Ready to choose? Here are the most-bought Roxy and SEDA SKUs.
Frequently Asked Questions
- Which has the stronger single tablet?
- SEDA, 250 mg versus Roxy's 100 mg.
- Which is cheaper per milligram?
- SEDA, $0.042/mg at the top versus Roxy's best of $0.15/mg.
- Which has the lighter entry dose?
- Roxy, with 20 mg tablets. SEDA starts at 50 mg.
- Which has a pseudo option?
- Only SEDA, the Pseudo 360 mg / 3 ct at 120 mg per tablet.
- Which is better for first-time 7-OH users?
- Roxy. Its 20 mg tier is genuine beginner territory; SEDA's floor is a full 50 mg.
- Are both brands lab-tested?
- Yes. Both run 7oh.com's standard batch panel covering alkaloid content, heavy metals, and microbial contamination.
- Are both legal to buy and ship?
- Legality varies by state. 7oh.com ships only to permitted jurisdictions. Consult a healthcare professional before use.
Keep Comparing
You Might Also Compare
- 7Stax vs Roxy — The original Roxy matchup on catalog depth.
- 7Tabz vs SEDA — SEDA's muscle against the five-rung ladder.
- PilPac vs SEDA — The original SEDA matchup on positioning.
- Limitless vs Roxy — Roxy's architecture against two-tier value.
Important safety information:
Products containing 7-hydroxymitragynine(7-OH) are sold for adult use only(21+). These statements have not been evaluated by the U.S. Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease. The FDA has raised safety concerns regarding concentrated 7-OH products; consult a qualified healthcare professional before use. Do not operate vehicles or machinery after use. Keep out of reach of children and pets. Laws vary by state, buyers are responsible for knowing applicable law.